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Excess antisense RNA from infectious recombinant SV40 fails to inhibit expression 
of a transfected, interferon-inducible gene 
Shona M. KERR, George R. STARK and Ian M. KERR 
Imperial Cancer Research Fund Laboratories, London 
(Received January 14/March 25, 1988) - EJB 88 0046 
SV40-based infectious virus constructs were used to produce a high copy number of full-length antisense RNA 
in essentially every cell in a population. Chloramphenicol acetyltransferase (CAT) cDNA was placed in either the 
sense or antisense orientation relative to the SV40 early promoter in helper-free recombinant virus. RNA 
synthesised at high levels from the antisense virus was without effect on the expression of a stably-transfected 
CAT mini-gene controlled by an interferon-inducible promoter in monkey CV1 and large T antigen-expressing 
tsCOS cells. In double infection experiments the antisense RNA was similarly without effect on expression from 
CAT cDNA placed in the sense orientation in a second virus vector. No activation of the ppp(A2’p),A(n 2 2) 
system was observed after interferon treatment in either type of experiment. There was no evidence, therefore, 
for the formation of double-stranded (ds)RNA. It can be concluded that a large excess of a full-length antisense 
RNA is not necessarily sufficient to cause inhibition of gene expression even when interferon treatment is used 
to enhance any effect of dsRNA. 
The ability of complementary strands of RNA to form 
a stable duplex provides a potentially powerful method of 
regulating RNA function. Complementary (antisense) RNA 
can inhibit specific gene expression in both eukaryotes (e.g. 
[I, 21) and prokaryotes (e.g. [3,4]). This use of antisense RNA 
as a molecular tool for genetic analysis has been extensively 
reviewed [5 - 71. 
Antisense RNA has been introduced into intact cells in a 
variety of ways. The precise mechanisms of the observed 
inhibition of gene expression are not, however, fully under- 
stood. In mammalian cells successful approaches have used 
plasmid constructs stably transfected into chromosomal DNA 
to synthesise the antisense RNA [2, 8-11]. Antisense 
oligodeoxynucleotides can also inhibit viral or cellular gene 
expression (e.g. [12, 131). No single approach, however, has 
been consistently effective in mammalian cells. In an optimal 
system every cell in the population should contain antisense 
transcripts in considerable excess over the target sense RNA. 
It is likely that a strong promoter will be required and, ideally, 
the level of the antisense RNA should be controllable. Here, 
a system using infectious (but defective) recombinant SV40 
constructs was developed to fulfil these conditions. High and 
regulatable levels of an antisense RNA complementary to 
chloramphenicol acetyltransferase (CAT) mRNA were 
obtained from the recombinant SV40 by supplying large T 
antigen (TAg) in trans in tsCOS cells. The effect of this anti- 
sense RNA was assayed on the expression of a stably-trans- 
fected, interferon-inducible CAT mini-gene construct. The ap- 
proach was also used to ask whether in the intact cell the sense 
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Abbreviations. ppp(ATp),A, (for n = 2), 5’-triphosphoadenylyl- 
(2’-5’)adenyly1(2’-5’)adenosine; CAT, chloramphenicol acetyltrans- 
ferase; dsRNA, double-stranded RNA; pi.,  post-infection; SV40, 
simian virus 40; TAg, large T antigen. 
Enzyme. Chloramphenicol acetyltransferase (EC 2.3.1.28). 
and antisense RNAs form double-stranded RNA (dsRNA) 
capable of activating the interferon-modulated ppp(A2’p)“A 
( n  2 2) system [14, 151. This was with a view to determining 
whether interferon could be used to enhance any inhibitory 
effect of antisense RNA through the localised activation [16 - 
181 of this system or the similarly modulated dsRNA-depen- 
dent protein kinase system [14, 151. 
METHODS 
Growth of cells: interferon treatment and virus infection 
Monkey CVI, CV1-P (from Dr P. Berg, Stanford Univer- 
sity, CA, USA) COS [19] and tsCOS [20] cells were grown in 
Dulbecco’s modified Eagle’s medium supplemented with 10% 
foetal calf serum. The tsCOS cells were maintained at 37°C 
but shifted to 32 “C in 10% COz for 14 - 24 h before interferon 
treatment or virus infection. Wellferon, a highly purified mix- 
ture of human &-interferons (> lo8 IU/mg protein [21]), was 
generously supplied by Dr K. Fantes of Wellcome Research 
Laboratories. Virus adsorption (90 min at 32°C) and growth 
was in medium containing 2% foetal calf serum. Zero time 
was taken as the time of addition of the virus. 
Transfeection procedures 
Cells were transfected with viral or plasmid DNA by a 
calcium phosphate procedure [22]. Cells were seeded at lo6/ 
90-mm-diameter dish and incubated overnight. Plasmid DNA 
(20 pg) or viral DNA (up to 5 pg mixed with carrier salmon 
sperm DNA from Sigma at 50 pg/ml) was added as a calcium 
phosphate precipitate. After 8- 16 h the cells were treated 
with glycerol (10% by vol. [22]). Cells transfected with viral 
DNA were maintained in medium containing 2% foetal calf 
serum. CV1 and tsCOS cells were stably transfected with an 
interferon-inducible CAT gene construct (p6-16cat, Fig. 2) 
1231 by co-transfection to hygromycin resistance using a molar 
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Fig. 1. Construction of the viral vectors vPScat and vNScat and characterisation of the D N A  in virus stocks. (A) Map of SV40 DNA showing 
the location of restriction enzyme sites relevant to the construction of the plasmid and viral vectors. The numbering of the nucleotide sequence 
of the DNA begins with the unique BgZI site at the origin [46]. The directions of early and late transcription are indicated and the position 
of the replication origin is shown together with the protein-coding regions. The position of the 'filler' DNA is also indicated. (B) Vector 
construction. The pSV2 vector was obtained by Hind111 and BgnI digestion of the plasmid pSV2P-globin. The regions derived from SV40 are 
shown unshaded, those from pBR322 are shaded. Step 1 : a CAT cDNA with blunt ends isolated from pSV2cat (Methods) was ligated to end- 
filled, phosphatase-treated pSV2 DNA and introduced into Escherichiu coli HBlOl by transformation, resulting in plasmids designated pPScat 
and pNScat, for proper sense and antisense respectively. Step 2: early region DNA containing the CAT insert was isolated from pPScat and 
pNScat after digestion with BgZI and BamHI. The two fragments are shown schematically with the insert in either orientation and triangles 
representing the positions of deletions with respect to the wild-type SV40 early region. Step 3 : wild-type SV40 DNA was cut with BgZI, BarnHl 
and NdeI and the BgZI -BamHI fragment from the late region was ligated to the early region DNA from pPScat and pNScat, resulting in the 
viral vectors vPScat and vNScat. (C) Chracterisation of the viral construct DNA. DNA from COS cells infected with vNScat (lanes 2 and 4), 
vPScat (lanes 3 and 5 )  or mock-infected (lane 1 )  was extracted by Hirt lysis (Methods) four days after infection with primary virus stocks 
harvested eight days after transfection of COS cells with the construct DNA. The viral DNA was either digested with PvuII (P) or left intact 
(-) and analysed by electrophoresis through an agarose gel, transfer to a nylon membrane and hybridisation with a nick-translated SV40 
DNA probe. The positions of the PvuII sites and the sizes of the expected DNA fragments are indicated in B 
ratio of p6-16cat to pY3 [24] of 1 O : l .  Stable transfectants 
were maintained in 100 pg/ml hygromycin B throughout. 
Virus growth 
Recombinant SV40 stocks were prepared from COS cells 
transfected with viral DNA. Primary virus was harvested 
when a cytopathic effect developed, usually after eight days. 
Phosphate-buffered saline (0.1 vol.) was added and the culture 
(cells plus medium) put through three freeze (- 20 T)/thaw 
cycles prior to sonication for 10 min in a Decon FSlOO ultra- 
sonic bath and storage at -2OT.  Secondary and tertiary 
stocks were prepared by infecting subconfluent COS cells with 
0.1 vol. of the appropriate stock and harvesting as above 
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Fig. 2. Structure ofp6-16cat DNA,  6-16cat mRNA. vNScat antisense RNA and vPScat sense RNA.  ( I )  Schematic representation of the p6-16cat 
plasmid, with the DNA from the 5’ end of the 6-16 gene, the CAT cDNA and SV40 3’ end sequences drawn to scale. The positions of the 
restriction enzyme sites used in the construction of the plasmid are numbered with respect to wild-type SV40 DNA (Fig. IA). (11) Predicted 
6-16cat mRNA from p6-16cat DNA. The RNA is shown starting at the normal site for 6-16 and containing a portion of the first 6-16 intron 
followed by the CAT sequences. At the 3’ end it is assumed that the small t antigen intron has been correctly spliced and that termination 
and polyadenylation have occurred normally within the SV40 DNA. The observed size of the major (longer) transcript (Fig. 5B) is consistent 
with the structure shown. (111) The predicted antisense RNA from vNScat is shown in the 3’ to 5‘ direction, to illustrate the region of 
complementarity. The 58-nucleotide 5’ sequence is derived from the SV40 early promoter and is followed by the antisense CAT sequence and 
sequences from the 3’ end of the SV40 early region spliced and polyadenylated as for 11. (IV) Predicted sense CAT mRNA from vPScat. This 
is equivalent to the antisense RNA from vNScat (111), appart from the orientation of the CAT inset 
after four days. Titres were measured by plaque assay on 
monolayers of CV-1 or CV1-P cells co-infected with helper 
virus tsB201 defective in the late region [25]. Viral DNA was 
isolated by the method of Hirt [26] and analysed by Southern 
transfer [27]. 
Construction of plasmid and viral vectors 
The constructions are illustrated schematically in Fig. 1. 
Standard techniques were used for the treatment of DNA 
with restriction endonucleases, calf intestinal phosphatase, T4 
DNA polymerase and the Klenow fragment of DNA 
polymerase I [28]. Plasmid DNA was prepared by alkaline 
lysis [29] and ultracentrifugation through caesium chloride. 
Plasmid constructs. A 775-bp CAT mini-gene containing 
29 bp upstream of the initiator ATG codon, the coding se- 
quence and 86 bp downstream of the translation termination 
codon was obtained by digestion of pSV2cat [30] with HindIII 
and Sau3A. The ends of the fragment were filled by treatment 
with the Klenow fragment of DNA polymerase I and ligated 
into the vector pSV2 [31], formed by digestion of pSV2B- 
globin [31] with Hind111 and BgZII (Fig. 1 B) [l]. The resulting 
plasmids containing CAT in either orientation were designat- 
ed pPScat and pNScat for proper sense and antisense respec- 
tively. 
Viral vectors. The above plasmids formed the basis for the 
recombinant SV40 viral vectors vPScat and vNScat, which 
were constructed by replacing pBR322 sequences with the late 
region of SV40 as described in Fig. 1. In addition, re- 
combinant SV40 viruses containing ‘filler’ DNA to increase 
their size were constructed for sense and antisense CAT and 
P-globin by inserting part (Fig. 1 A) of the open reading frame 
of the TAg (Fig. 1A) previously deleted in the construction 
of the pSV2 vector. For example, in the case of the globin 
constructs the Sgu3A fragment 3716 -2771 in wild-type SV40 
was cloned into the unique BglII site of pSV2P-globin. The 
resulting plasmid was digested with HindIII and a j-globin 
cDNA insert (derived from pSV2a-globin) inserted in either 
orientation. The resulting sense and antisense plasmids pPSP- 
globin and pNSB-globin were converted into viral DNA 
using the procedure outlined above. The plasmid p6-16cat 
(Fig. 2, I) [23], kindly provided by Dr A. C. G. Porter, was 
constructed by ligating an end-filled BglII/SmaI fragment 
containing 1040 bp of 6- 16 DNA into pSVOcat, linearised 
at the unique HindIII site [30]. 
Preparation of RNA from CVI and tsCOS cells 
Cells were harvested and lysed in NP40 buffer (0.65%, by 
vol., NP40, 0.15 M NaCl, 1.5 mM MgCl,, 10 mM Tris/HCl 
pH 7.9) and nuclei pelleted by centrifugation. RNA was ex- 
tracted from the cytoplasmic fraction with 4 M guanidinium 
thiocyanate, 0.5% sodium N-lauryl sarcosine, 25 mM sodium 
citrate, pH 7.0. The RNA was recovered by centrifugation 
through a 5.7 M CsCl gradient, precipitated with ethanol and 
stored in 10 mM Tris/HCl pH 7.2, 1 mM EDTA at -80°C. 
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Northern analysis of RNA 
Aliquots of RNA ( 5  - 20 pg) were glyoxalated, fractionat- 
ed through 1 - 1.4% agarose gels and transferred to nylon 
membranes (Pall Corp.) [32]. These were baked at 80°C for 
2 h, pre-hybridised for 8-24 h and hybridised with 32P- 
labelled single-stranded M13 or double-stranded DNA probes 
in 50% formamide, 0.9 M NaCl, 5 mM EDTA, 50 mM so- 
dium phosphate pH 7.4, 5 x Denhardt's solution, 0.2% SDS 
and 100 pg/ml denatured salmon sperm DNA for 18-36 h 
at 42°C. The 775-bp CAT mini-gene labelled to > 10' cpm/ 
pg by the random priming technique [33] provided a double- 
stranded probe. The same CAT fragment was cloned into the 
SmaI site of the double-stranded DNA replicative form of 
the single-stranded DNA bacterophage M13mp18 [34] and 
strand-specific probes were prepared by labelling purified 
single-stranded recombinant M13 DNA [35]. For slot blot 
analysis the RNA samples were denatured in 6 x SSC (SSC = 
0.15 M NaC1, 0.15 M sodium citrate, pH 7 3 ,  7.4% form- 
aldehyde prior to transfer to nylon membranes and hy- 
bridisation as above. The membranes were washed for 1 h in 
2 x SSC, 0.1 % SDS at 60 "C, then for 1 h in 0.2 x SSC, 0.1 % 
SDS at 60°C. Kodak XAR-5 film was used for 
autoradiography. Levels of RNA were compared by scanning 
the appropriate bands in the linear range of response on 
autoradiographs. Filters were re-hybridised with different 
probes after removing the bound probe by incubation in 
10 mM Tris/HCl, pH 7.5, 1 mM EDTA in a shaking water 
bath at 75 "C for 30 min. 
Assay of CAT activity 
Cells were pelleted and lysed in NP40 buffer as described 
above for the preparation of RNA. A tenth of the volume of 
each extract was assayed for CAT activity by a rapid 
nonchromatographic method [36]. Where necessary, lysates 
were diluted to ensure that the assay was in the linear range. 
In all experiments the interferon-induced level of activity in 
the CAT assay was at least 2000 cpm above the background 
(zero-time) value. The protein content of each extract was 
measured spectrophotometrically using the Bio-Rad dye re- 
agent [3 71. 
RESULTS 
Construction and characterisation of recombinant S V40 vectors 
Infective SV40 constructs were designed (Fig. 1, Methods) 
to introduce antisense RNA into every cell in a given popu- 
lation. Propagation in COS cells [19] resulted in helper-free 
virus stocks in which there was no detectable rearrangement 
of the viral DNA (Fig. 1C). As expected for recombinant 
viruses defective in the early region, infection of monkey CV1 
cells, even at high multiplicity, did not cause any cytopathic 
effect over a period of at least 10 days. 
Bacterial CAT and rabbit p-globin cDNAs were inserted 
into the vectors in both possible orientations yielding DNA 
of approximately 80% of wild-type genome size (Fig. 1). 
Titres of between 5 x lo6 and 1 x 10' pfu/ml were obtained 
for viruses containing inserts in either the sense (vPScat, vPSfl- 
globin) or antisense (vNScat, vNSP-globin) orientations. This 
is low compared with wild-type SV40, but is in the upper 
range of the values expected for a recombinant SV40 system 
(Dr Y. Gluzman, Cold Spring Harbor Laboratories, NY, 
USA, personal communication). Addition of 'filler' DNA (see 
Methods) to increase the size to approximately that of wild- 
type virus DNA did not increase the titre. The titres were, 
however, sufficiently high to allow infection of every cell with 
up to 50 pfu of virus in small-scale experiments. 
A transcript corresponding to the entire CAT protein- 
coding sequence plus 29 nucleotides of 5'- and 86 nucleotides 
of 3'-flanking sequence in the antisense orientation would be 
expected to by synthesised from the SV40 early promoter in 
the antisense virus vNScat (Fig. 2, 111). This antisense RNA 
was targeted against a CAT mRNA (Fig. 2, 11) produced 
from an interferon-inducible CAT cDNA construct (p6-16cat, 
Fig. 2, I) [23] stably transfected into the genomic DNA of 
CV1 and TAg-expressing tsCOS cells. Expression of CAT 
from this construct is driven by transcriptional control se- 
quences from the 5' end of the human interferon-inducible 
gene 6-16 [23,27] permitting a high degree of induction of gene 
expression from a low basal level in response to interferon. 
Together these components provided a model system to inves- 
tigate the feasibility of inhibiting the expression of an en- 
dogenous interferon-inducible gene with antisense RNA. 
Interferon-inducible expression of CAT in CVI and tsCOS cells 
stably transfected with an interferon-inducible CAT plasmid 
The structure of the p6-16cat plasmid, stably-transfected 
into CV1 and tsCOS cells (Methods), is schematically illustrat- 
ed together with the predicted 6-16cat mRNA in Fig. 2, I and 
11. Individual clones of transfectants were expanded into cell 
lines in which the structure and copy number of the integrated 
6-16cat DNA should be the same in each cell. Several of these 
clones were analysed for the kinetics and dose response of 
induction of CAT expression in response to IFN treatment. 
Similar results were obtained for the CV1 and tsCOS clones 
at both 32°C and 37°C. CAT activity was inducible up to at 
least 50-fold from a level close to background. A small in- 
crease was observed with 1 IU/ml. A nearly maximal re- 
sponse was obtained at 1000 IU/ml, the concentration chosen 
for use in the antisense experiments. At this concentration 
CAT activity in, for example, tsCOS.6-l6cat clone 1 cells 
increased for at least 20 h after treatment with interferon 
(Fig. 3). 
Analysis of the sense 6-16cat transcripts in the stably trans- 
fected CV1 and tsCOS cell clones revealed low levels of two 
interferon-inducible RNAs (for example, Fig. 5 B). One was 
of the expected size (Fig. 2, II), the other smaller, perhaps 
reflecting the use of a cryptic splice site. Induction of the sense 
6-16cat RNAs paralleled CAT activity in the CV1.6-16cat 
and tsCOS.6-16cat cells. Both transcripts were found to be 
relatively stable (half-life > 8 h) in the presence of actinomycin 
D in tsCOS.6-l6cat cells (data not shown). 
Accumulation of antisense R N A  from vNScat in tsCOS cells 
Three strategies were used to maximise the level of anti- 
sense RNA synthesised from vNScat relative to the inducible 
sense CAT mRNA, in order to increase the probability of 
success in inhibiting CAT expression. Firstly, as early gene 
expression from the recombinant viruses was at least 10-fold 
higher in monkey CV1 cells than in several human and mouse 
cell lines (data not shown), high multiplicity infection of 
monkey cells was used. Secondly, TAg was supplied in trans 
to allow the viral DNA to replicate, increasing the number of 
templates for transcription of antisense RNA. Thirdly, the 
experiments were designed to allow high levels of antisense 
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Fig. 3. Kinetics of interferon-inducible CAT expression in stably trans- 
fected cells. tsCOS cells stably transfected with p6-16cat (tsCOS.6- 
16cat, clone 1)  were incubated at 37°C with (-) or without 
(- - - -) 1000 IU/ml interferon for the times indicated and assayed 
for CAT activity (Methods). Specific activities are given (ordinate); 
the observed value for the induced enzyme was > 2000 cpm above 
background 
Fig. 4. Accumulation of antisense R N A  from vNScat in tsCOS.6-16cat 
cells: comparison with CVI cells. tsCOS.6-l6cat clone 1 and CV1 cells 
were either infected with vNScat (20 pfu/cell) (+), or mock-infected 
(-), incubated at 32°C (tsCOS) or 37°C (CVI), harvested at the 
indicated times p.i., frozen and lysed in NP40 buffer. The cytoplasmic 
RNA was extracted in guanidinium thiocyanate and centrifuged 
through caesium chloride gradients (Methods). RNA samples (1 1 hg 
CV1, 15 pg tsCOS) were electrophoresed in a 1.4% (mass/vol.) 
agarose gel, blotted onto nylon membranes and hybridised to a 
double-stranded 32P-labelled M13cat DNA probe. Size markers (in 
kb) are indicated to the right 
RNA to accumulate before induction of the sense 6-16cat 
RNA by interferon. 
Individual COS cells express variable amounts of TAg [19]. 
In contrast, for both tsCOS and tsCOS.6-16cat clone 1 cells 
immunological staining showed a high and uniform level of 
TAg expression on shift down to 32°C (data not presented). 
Accordingly uniform expression of antisense RNA from 
vNScat would be expected in these cells. Antisense RNA from 
vNScat of the predicted size (Fig. 2, 111) accumulated to very 
high levels, with a strong signal 48 h post-infection (p.1.) and 
a further increase up to 62 h p.i. (Fig. 4). By comparison, 
CV1 cells infected with vNScat accumulate substantially lower 
levels of antisense RNA (Fig. 4). Allowing for the fact that 
the antisense RNA accumulates more rapidly at 37°C in the 
CV1 cells than at 32°C in the tsCOS cells, densitometric 
scanning of autoradiographs indicated that there was an 
approximately 40-fold differential. Similar results were 
obtained with a second independent clone of tsCOS.6-l6cat 
cells. 
It would be disadvantageous if synthesis of RNA from 
vNScat were decreased by interferon treatment. Interferon, 
however, exerts its antiviral action on SV40 before the onset 
of early transcription, possibly at the uncoating stage and is 
only antiviral if added prior to virus uptake [38, 391. As 
expected, control experiments showed that treatment with 
interferon 2-3 days p i ,  as in the present antisense exper- 
iments in CV1 and tsCOS cells, had no effect on early gene 
expression from vNScat (data not shown). 
Antisense R N A  from vNScat fails to inhibit inducible CAT 
expression 
Lack of inhibition of interferon-inducible CAT in stably- 
transfected tsCOS and CVI cells. A series of antisense exper- 
iments in clones of tsCOS.6-16cat and CV1.6-16cat cells 
showed a uniform lack of inhibition of interferon-inducible 
CAT activity by vNScat ( e g  Table 1). The experimental strat- 
egy was based on the kinetics of accumulation of antisense 
RNA and induction of CAT expression by interferon de- 
scribed above. The interferon treatment was kept relatively 
short to ensure that at the time of harvest new CAT protein 
was being synthesised in small amounts in the linear range of 
response in the presence of a large excess of preformed anti- 
sense RNA. The vNSB-globin virus provided a control for 
possible non-specific effects caused by infection with re- 
combinant virus (Table 1). 
The lack of inhibition of CAT activity made it particularly 
important to analyse sense and antisense RNA extracted from 
the same cell lysates. A Northern blot of RNA from the 
tsCOS.6-l6cat clone 1 cells, assayed for CAT activity in exper- 
iment 2 of Table 1, was probed first with double-stranded 
CAT DNA to detect both sense and antisense RNA, then 
stripped and re-hybridised with a strand-specific probe to 
CAT mRNA (Fig. 5, A and B respectively). It is clear that 
there is a large excess of antisense RNA over 6-16cat sense 
RNA. There was a similar lack of inhibition of CAT activity 
by lower levels of antisense RNA in CV1 cells (data not 
shown). In several experiments in tsCOS.6-I 6cat cells the ex- 
cess of antisense RNA from vNScat to the induced sense 
RNA was estimated to be at least 300-fold. For example, in 
experiment 1 of Table 1, the excess was > 1000-fold (Fig. 5C). 
In agreement with this, CAT expression from the analogous 
sense virus, vPScat, was approximately 350-fold higher than 
that from the stably transfected p6-16cat gene induced with 
IFN (Table 1, expt 1). 
If dsRNA is formed in interferon-treated cells, activation 
of the ppp(A2'p),A system with cleavage of mRNA by the 
~pp(A2'p)~A-dependent ribonuclease would be predicted (re- 
viewed in [14, 151). Strand-specific probing revealed no de- 
crease in the size or abundance of 6-16cat mRNA in samples 
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Table 1 .  Absence of an effect of antisense R N A  from vNScat on expression of interferon-inducible CAT in tsCOS and CVl cells 
Clones of tsCOS and CV1 cells stably transfected with p6-16cat were mock-infected or infected with vPScat, vNScat or vNSP-globin at the 
multiplicities shown. In expt 1 the cells were incubated at 32°C throughout. In expt 2 they were shifted from 32°C to 40°C 47 h p i  Interferon 
treatment (1000 IU/ml) was at 58 h (expt I), 62 h (expt 2) or 48 h (expt 3) p i .  Cells were harvested 72 h (expts 1 and 2) or 60 h (expt 3) p i .  
Extracts were assayed and the specific activity of the CAT was calculated (Methods) 
Expt Cell line Interferon Virus 
~~~ 
CAT activity 
vPScat vNScat vNSP-globin 
pfu/cell cpm pg-' h-'  
1. tsCOS.6-16cat - 
clone I + + + 
2. tsCOS.6- 16cat 
clone I1 
3. CV 1.6- 1 6cat 
clone V 
5 - 
20 
- 
20 
- 
30 
30 
5 
42 
17500 
49 
5 
28 
25 
2 
30 
29 
29 
Fig. 5. Analysis and quantification of sense and antisense RNA in tsCOS.6-16 cat cells infected with vNScat and treated with interferon. tsCOS.6- 
16cat clone 1 cells were (1 and 2) mock-infected or (3) infected at 32°C with vNScat (20 pfu/cell) shifted to 40°C at 47 h p.i. and (2 and 3) 
treated with IFN (1000 IU/ml), at 62 h (expt 2, Table 1). All cells were harvested 72 h p.i. and cytoplasmic RNA was extracted as in Fig. 4. 
Samples (8 pg) were electrophoresed in a 1.4% (massjvol.) agarose gel-transferred onto nylon membranes and hybridised (A) to a nick- 
translated double-stranded M13cat DNA probe and (B), after stripping, re-hybridised to a strand-specific 32P-labelled MI3 probe to CAT 
mRNA. The arrows show the position of the antisense (A) and sense (B) RNAs and size markers (in kb) are shown. The signal from the 
material migrating more slowly arose from spurious hybridisation with 28s rRNA. (C) Slot blot analysis of RNA prepared as above but from 
the same cells as were used in expt 1 in Table 1. RNA (10 pg) was from tsCOS.6-16cat clone 1 cells without (slots a I and 11) or with (b 11) 
interferon (1000 IU/ml) treatment from 58 h to 72 h. The remainder of the RNA samples were from cells infected with vNScat (20 pfu/cell) 
and treated with interferon (1000 IU/ml) from 58 h to 72 h: b I, 1 pg RNA; c I and I1 and d I and 11, 0.1 and 0.01 pg RNA, respectively. 
Hybridisation was to a double-stranded 3ZP-labelled MI3 CAT probe (Methods) 
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Table 2. Absence of an effect of antisense RNA .from vNScat on ex- 
pression of CAT from vPScat 
tsCOS cells incubated at 32°C for 24 h were infected with vNScat or 
vPSB-globin or mock-infected. After a further 48 h at 32°C they were 
infected with vPScat and harvested 17 h later. Extracts were assayed 
and the specific activity of the CAT calculated (Methods). Averages 
from duplicate plates of cells are presented 
Virus CAT activity 
vNScat vPScat vPSP-globin 
~ 
pfu/ceil cprnpg- lh- '  
- 10 
60 10 
- 10 60 
- 
- 
595 
645 
750 
Fig. 6. Analysis of CAT mRNA in cells co-infected with viruses coding 
sense and antisense RNA. RNA was from CV1 cells (lane 6) or CV1 
cells infected with (1) vNScat (1 pfu/cell); (2) vPScat (1 pfu/cell); (3) 
vPScat and vNScat (1 and 10 pfu/cell, respectively); (4) vPScat and 
vNScat (1 and 10 pfu/cell) respectively and treated with 1000 IU/ 
ml interferon 21 -48 h p i ;  (5) vPScat (1 pfu/cell) and treated with 
interferon 21 -48 h p i .  All cells were harvested at 48 h and cytoplas- 
mic RNA was prepared from NP40 lysates by phenol/chloroform 
extraction (Methods). Samples (20 pg) were denatured by glycoxala- 
tion, electrophoresed in a 1.8% (massivol.) agarose gel and transferred 
to a nylon membrane. Hybridisation was with a strand-specific 32P- 
labelled MI3 DNA probe to CAT mRNA (Methods). The positions 
of single-stranded DNA markers are indicated in kb to the right and 
viral DNA (Methods) and CAT mRNA to the left of the auto- 
radiograph 
in which there was an excess of antisense CAT RNA (Fig. 5B), 
nor was cleavage of rRNA to characteristic products, a highly 
sensitive assay for activation of the ~pp(A2'p)~A-dependent 
RNase [40], observed. No evidence was, therefore, obtained 
for dsRNA formation and activation of the ppp(A2'p),,A 
system in these experiments. 
It can be concluded that, in this system, a large excess of 
antisense RNA is not in itself sufficient to cause inhibition of 
CAT activity or, in the presence of interferon, degradation 
of RNA. In case this somewhat surprising result reflected a 
problem unique to the 6-16cat mRNA (Fig. 2, II), it was 
decided to use another approach in which a different sense 
CAT transcript (Fig. 2, IV) was synthesised from a second 
recombinant virus. In addition, double infection experiments 
have the advantage that it is unlikely that separate 
compartmentalisation of the sense and antisense transcripts 
within the cell could occur. 
Double infection experiments. The sense virus vPScat ex- 
presses a single early region transcript (Fig. 2, IV) which is 
equivalent in structure to the antisense RNA from vNScat 
(Fig. 2, 111), apart from the orientation of the CAT insert. 
Initial double infection experiments involved simultaneous 
co-infection of CV1 cells with vPScat and vNScat. Once again, 
RNA analysis did not reveal cleavage of sense mRNA (Fig. 6) 
or rRNA (data not shown) in the doublv-infected cells desDite 
obtained with or without interferon treatment. In this system 
the excess of antisense to sense RNA was 3 - 10-fold. A sub- 
stantially greater excess was obtained by infecting tsCOS cells 
with vNScat and allowing replication of the viral DNA before 
infection with vPScat. Despite this no inhibition of the ex- 
pression of CAT activity from the sense virus occurred 
(Table 2). 
DISCUSSION 
It is extremely probable that the recombinant SV40 system 
used here achieved the objective of introducing high levels 
of antisense RNA into virtually every cell in a population. 
Sufficient virus was used to infect every cell, the tsCOS cells 
expressed a uniformly high level of TAg and a massive overall 
excess of antisense to sense RNA expression was achieved. 
Despite this, the antisense CAT RNA was without effect on 
the expression of CAT either from an interferon-inducible 
construct (Table 1, Fig. 5)  or a second recombinant virus 
(Table 2, Fig. 6).  Comparison with other systems provides no 
obvious explanation for this. Several examples of inhibition of 
expression of stably-integrated or endogenous chromosomal 
genes by antisense RNA synthesised from stably-transfected 
plasmid DNA have been reported for mammalian cells [2,8 - 
111. In one case no inhibitory effect was detectable until the 
copy number of the antisense plasmid was increased by gene 
amplification [8]. In another a 10-20-fold excess of antisense 
RNA had no detectable effect [42]. In contrast, however, a 
very small excess can be effective (e.g. [lo]). Here the ratio 
of antisense to sense RNA observed in the tsCOS cells was 
routinely in excess of 300 (e.g. > 1000, Fig. 5C). It seems 
unlikely that it was insufficiently high. 
Nor is there any obvious reason why the antisense RNA 
from vNScat should be ineffective. The vNScat was construct- 
ed to yield RNA complementary to the entire CAT insert 
consisting of the protein coding sequence, 29 nucleotides of 
5' and 86 nucleotides of 3' untranslated sequence (Fig. 2,111). 
Targeting to intron sequences and intron-exon boundaris (e.g. 
[lo]) may be more effective than targeting to only mature 
(exon) seauence RNA. However. the TK gene. which has been 
I .  Y I  
interferon'treatment from21 h to 48 h p i  Similar results \;ere used extensively in antisense experiments [l, 81, lacks introns; 
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antisense RNAs directed solely against mature mRNA se- 
quences have also proved effective (e.g. [9]). The particular 
structure of the vNScat antisense RNA could be unsuitable 
for causing inhibition of gene expression. However, the viral 
vector vNScat is analogous to the SV40-based plasmid vector 
pNSlacZ with which a potent antisense effect was obtained in 
transient expression experiments [41]. This latter effect was 
not obviously potentiated by treatment with interferon 
(S.M.K., John Rubenstein, G.R.S. and I.M.K., unpublished 
data). Furthermore, an RNA very similar in structure to that 
made by the vNScat used here, but synthesised from a 
plasmid, effectively inhibited CAT activity in transient ex- 
pression transfections in mouse cells [2]. Also microinjection 
of antisense CAT RNA synthesised in vitro inhibited the trans- 
lation of sense CAT RNA in Xenopus oocytes [43]. There is 
no reason, therefore, to suppose that antisense CAT RNA 
should be in any way intrinsically unsuited to antisense exper- 
iments. Similarly, the fact that negative results were obtained 
here in both stable transfection and double infection exper- 
iments, involving different structures for the sense CAT 
mRNAs (Fig. 2, 11 and IV), suggests that it is unlikely that 
any peculiarity in the sense CAT transcripts was responsible 
for the lack of inhibition. 
Although inhibition in the reports quoted above was not 
of an integrated CAT gene, the results imply that when both 
sense and antisense CAT RNAs are produced in the same 
cell hybridisation to form dsRNA occurs. No evidence for 
formation of dsRNA was, however, obtained here, despite the 
use of interferon to potentiate any inhibitory effect. General- 
ised activation of the interferon-mediated, dsRNA-dependent 
ppp(A2’p),,A system did not occur, nor was nucleolytic cleav- 
age of the sense CAT RNA observed (Fig. 5B). The latter 
would have been expected if the localised activation hypoth- 
esis for the ppp(A2’p),A system [14] is correct and if the 
partially dsRNA structures predicted for the hybridisation of 
the sense and antisense CAT RNAs (cf. 11,111 and IV, Fig. 2) 
were indeed fornied in the intact cell. It seems unlikely that 
failure to activate the ppp(A2’p),A system reflects any intrin- 
sic defect in that system. We know that the CV1 cells have a 
fully activatable ppp(A2’p),A system, induction of synthetase 
mRNA was monitored in some of the experiments and we 
have no reason to believe that the tsCOS cells (derived from 
CVls) are in any way defective in this regard. Compart- 
mentalisation separating the sense and antisense transcripts 
in the cell could have occurred, but seems extremely improb- 
able in the double infection experiments. A dsRNA unwinding 
activity capable of preventing microinjected antisense RNA 
from inhibiting gene expression in Xenopus eggs has recently 
been described [44, 451. It cannot be excluded that an anal- 
ogous activity is present at unusually high levels in the tsCOS 
cells used here and the CV1 cells from which they were derived. 
For the moment, however, the reason for the apparent failure 
of dsRNA to form or accumulate remains unclear. Equally, 
it remains possible that with alternative systems interferon 
treatment of cells could be useful in potentiating a specific 
antisense effect. This might be particularly true for antisense 
constructs corresponding to the 3’ ends of mRNAs, which are 
generally less effective in inhibiting gene expression but could 
form partially dsRNA capable of activating the interferon- 
mediated dsRNA-dependent pathways. 
In conclusion, in these model systems, antisense RNA 
synthesised by recombinant SV40 did not inhibit CAT ex- 
pression from either a virally-introduced or a stably-trans- 
fected, interferon-inducible CAT construct. Accordingly, 
although a large excess of an appropriate antisense RNA over 
sense RNA may be desirable, it is not necessarily sufficient to 
cause inhibition of gene expression. 
We thank A. C. G. Porter for plasmids and helpful discussions 
and M. Brennan for advice on the construction of recombinant SV40 
vectors. 
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